[1] Lai C S,Vassilev V P,Wang T M. Method for in Vivo Reduction of Nitric Oxide Levels and Compositions Useful Therefor:US Pat.5847004[P],1998. [2] Hidaka S,Funakoshi T,Shimada H, et al . Comparative Effects of Diethyldithiocarbamate and n -Benzyl- D -Glucamine Dithiocarbamate on cis -Diamminedichloroplatinum-Induced Toxicity in Kidney and Gastrointestinal Tract in Rats[J]. J Appl Toxicol ,1995,15(4):267-273. [3] Tandon S K,Singh S,Jain V K, et al . Chelation in Metal Intoxication XXXⅧ:Effect of Structurally Different Chelating Agents in Treatment of Nickel Intoxication in Rat [J]. Fundam Appl Toxicol ,1996,31(2):141-148. [4] Imamura H,Ohtake N,Jona,H, et al . Structure-activity Relationships of trans -3,5-Disubstituted Pyrrolidinylthio-1 β -methylcarbapenems.Part 1:J-111,347 and Related Compounds[J]. Bioorg Med Chem Lett ,2000,10(2):109-113. [5] Len C,Boulognemerlo A S,Posted D J. Synthesis and Antifungal Activity of Novel Bis(dithiocarbamate) Derivatives of Glycerol[J]. J Agric Food Chem ,1996,44(9):2856-2858. [6] Menezes D C,Vieira F T,de Lima G M, et al . Tin(Ⅳ) Complexes of Pyrrolidinedithiocarbamate:Synthesis, Characterisation and Antifungal Activity[J]. Eur J Med Chem ,2005,40(12):1277-1282. [7] Schreck R,Meier B,Mannel D N, et al . Dithiocarbamates as Potent Inhibitors of Nuclear Factor Kappa B Activation in Intact Cells[J]. J Exp Med ,1992,175:1181-1194. [8] Ha T,Li Y,Gao X, et al . Attenuation of Cardiac Hypertrophy by Inhibiting both mTOR and NFκB Activation in vivo [J]. Free Radic Biol Med ,2005,39(12):1570-1580. [9] Mehta G R,Liu J,Constantinou A, et al . Cancer Chemopreventive Activity of Brassinin, a Phytoalexin from Cabbage[J]. Carcinogenesis ,1995,16(2):399-404. [10] Robert M M,Rajesh N,Jerome K, et al . Cancer Chemopreventive Activity of Sulforamate Derivatives[J]. Eur J Med Chem ,2006,41(1):121-124. [11] Pedras M S,Loukaci A,Okanga F I. The Cruciferous Phytoalexins Brassinin and Cyclobrassinin are Intermediates in the Biosynthesis of Brassilexin[J]. Bioorg Med Chem Lett ,1998,8(21):3037-3038. [12] Gaspari P,Banerjee T,Malachowski W P, et al . Structure-Activity Study of Brassinin Derivatives as Indoleamine 2,3-Dioxygenase Inhibitors[J]. J Med Chem ,2006,49(2):684-692. [13] Péter C,István Z,Borbála R, et al . Isobrassinin and Its Analogues:Novel Types of Antiproliferative Agents[J]. Bioorg Med Chem Lett ,2006,16(24):6273-6276. [14] Zhang Y,Kensler T W,Cho C G, et al . Anticarcinogenic Activities of Sulforaphane and Structurally Related Synthetic Norbornyl Isothiocyanates[J]. Proc Natl Acad Sci USA ,1994,91(8):3147-3150. [15] Gerhäuser C,You M,Liu J F, et al . Cancer Chemopreventive Potential of Sulforamate, a Novel Analogue of Sulforaphane That Induces Phase 2 Drug-metabolizing Enzymes[J]. Cancer Res ,1997,57(2):272-278. [16] WEI Jun,CHENG Tieming,LI Runtao. Improved Synthesis of Sulforamate, a Cancer-chemopreventive Compound[J]. Chinese J Med Chem ,2002,47(12):159-160(in Chinese). 卫军,程铁明,李润涛. 化学防癌化合物sulforamate的合成改进[J]. 中国药物化学杂志,2002,47(12):159-160. [17] Kosmeder II J W,Hirschelman W H,Song L S, et al . Cancer Chemopreventive Activity of Oxomate:A Monfunctional Inducer of Phase Ⅱ Detoxification Enzymes[C]. 224th ACS National Meeting: Division of Medicinal Chemistry,2002:98. [18] Hirschelman W H,Kosmeder II J W,Song L S, et al . Design and Lead Optimization of Oxomate:A Novel Phase II Enzyme Inducer[C]. 224th ACS National Meeting:Division of Medicinal Chemistry,2002:178. [19] Hirschelman W H,Li Y M,van Breemen R B, et al . Synthesis of Oxomate Metabolites: Potential Chemopreventive Agents[C]. 225th ACS National Meeting:Division of Medicinal Chemistry,2003:86. [20] Chen D,Dou Q P. New Uses for Old Copper-binding Drugs:Converting the Pro-angiogenic Copper to a Specific Cancer Cell Death Inducer[J]. Expert Opin Ther Targets ,2008,12(6):739-748. [21] Chen D,Cui Q C,Yang H J, et al . Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome Activity[J]. Cancer Res ,2006,66(21):10425-10433. [22] Pang H,Chen D,Cui Q C, et al . Sodium Diethyldithiocarbamate, an Aids Progression Inhibitor and a Copper-Binding Compound, Has Proteasome-Inhibitory and Apoptosis-Inducing Activities in Cancer Cells[J]. Int J Mol Med ,2007,19(5):809-816. [23] Ziegler-Heitbrock H W,Sternsdorf T,Liese J, et al . Pyrrolidine Dithiocarbamate Inhibits Nf-Kappa B Mobilization and Tnf Production in Human Monocytes[J]. J Immunol ,1993,151(12):6986-6993. [24] Cen D,Brayton D,Shahandeh B, et al . Disulfiram Facilitates Intracellular Cu Uptake and Induces Apoptosis in Human Melanoma Cells[J]. J Med Chem ,2004,47(27):6914-6920. [25] Verhaegen S,McGowan A J,Brophy A R, et al . Inhibition of Apoptosis by Antioxidants in the Human Hl-60 Leukemia Cell Line[J]. Biochem Pharmacol ,1995,50(7):1021-1029. [26] Cao S L,Feng Y P,Jiang Y Y, et al . Synthesis and in Vitro Antitumor Activity of 4(3 H )-Quinazolinone Derivatives with Dithiocarbamate Side Chains[J]. Bioorg Med Chem Lett ,2005,15(7):1915-1917. [27] Cao S L,Feng Y P,Zheng X L, et al . Synthesis of Substituted-benzylamino- and Heterocyclylmethylamino-carbodithioate Derivatives of 4(3 H )-Quinazolinone and Their Cytotoxic Activity[J]. Arch Pharm ,2006,339(5):250-254. [28] Cao S L,Wang Y,Zhu L, et al . Synthesis and Cytotoxic Activity of N -((2-Methyl-4(3 H )-quinazolinon-6-yl) methyl) dithiocarbamates[J]. Eur J Med Chem ,2010,45(9):3850-3857. [29] Cao S L,Han Y,Yuan C Z, et al . Synthesis and Antiproliferative Activity of 4-Substituted- Piperazine-1-Carbodithioate Derivatives of 2,4-Diaminoquinazoline[J]. Eur J Med Chem ,2013,64:401-409. [30] Guo B B,Ge Z M,Cheng T M, et al . Synthesis and Anti-Tumor Activities of 1,4-Bis [3-(Amino-Dithiocarboxy) Propionyl] Piperazine Derivatives[J]. Acta Pharmaceutica Sinica ,2001,36(3):185-187. [31] Li R T,Cheng T M,Cui J R. Study on the Synthesis and Anticancer Activity of Dithiocarbamate:US Pat.1328999[P],2002. [32] JIANG Xiaomei,LING Xiaomei,LI Runtao, et al . Analysis of Hydrochloride 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3,3-diphenyl-propyl Ester and Its Metabolites in Rats by HPLC-ESI/ITMSn[J]. Acta Pharmaceut Sin ,2006,41(11):1084-1089(in Chinese). 姜小梅,凌笑梅,李润涛,等. HPLC-ESI/ITMS n 法分析大鼠体内4-甲基哌嗪-1-二硫代甲酸-(3-氰基-3,3-二苯基)丙酯盐酸盐及其主要代谢物[J]. 药学学报,2006,41(11):1084-1089. [33] Zhang N,Guo W,Wang L, et al . Effect of TM208 on QGY-7703 Xenograft Tumor Growth[J]. Anticancer Drugs ,2008,19(6):593-598. [34] Hou X L,Ge Z M,Wang T M, et al . Dithiocarbamic Acid Esters as Anticancer Agent.Part 1:4-Substituted-Piperazine-1-Carbodithioic Acid 3-Cyano-3,3-Diphenyl-Propyl Esters[J]. Bioorg Med Chem Lett ,2006,16(16):4214-4219. [35] Ning M R,Li Liang,Li J. In Vitro Screening of Reversible and Time-Dependent Inhibition on Cyp3a by Tm208 and Tm209 in Rat Liver Microsomes[J]. Acta Pharmaceut Sin B ,2012,2(2):181-187. [36] Kong D T,Ling,X M,Han F B, et al . Identification of the Metabolite and Cytochrome P450 Isoforms Involved in Rat Liver Microsomal Metabolism of TM208[J]. J Chin Pharm Sci ,2008,17:30-34. [37] Zahrana M A H,Salemb T A R,Samaka R M, et al . Design, Synthesis and Antitumor Evaluation of Novel Thalidomide Dithiocarbamate and Dithioate Analogs against Ehrlich Ascites Carcinoma-Induced Solid Tumor in Swiss Albino Mice[J]. Bioorg Med Chem ,2008,16(22):9708-9718. [38] Qian Y,Ma G Y,Yang Y, et al . Synthesis, Molecular Modeling and Biological Evaluation of Dithiocarbamates as Novel Antitubulin Agents[J]. Bioorg Med Chem ,2010,18(12):4310-4316. [39] Huang W,Ding Y,Miao Y, et al . Synthesis and Antitumor Activity of Novel Dithiocarbamate Substituted Chromones[J]. Eur J Med Chem ,2009,44(9):3687-3696. [40] Bacharaju K,Jambula S R,Sivan S, et al . Design, Synthesis, Molecular Docking and Biological Evaluation of New Dithiocarbamates Substituted Benzimidazole and Chalcones as Possible Chemotherapeutic Agents[J]. Bioorg Med Chem Lett ,2012,22(9):3274-3277. [41] Wang X J,Xu H W,Guo L L, et al . Synthesis and in Vitro Antitumor Activity of New Butenolide-Containing Dithiocarbamates[J]. Bioorg Med Chem Lett ,2011,21(10):3074-3077. [42] Wang X J,Xu H W,Guo L L, et al . Synthesis of Various Substituted Spiro- and Bicyclethiazolidine-2-Thiones by a Multicomponent Reaction and Biological Evaluation in Vitro [J]. Heterocycles ,2011,83(5):1005-1012. [43] Duan Y,Ma Y,Zhang E, et al . Design and Synthesis of Novel 1,2,3-Triazole-Dithiocarbamate Hybrids as Potential Anticancer Agents[J]. Eur J Med Chem ,2013,62:11-19. [44] Duan Y,ZhengY,Li X, et al . Design, Synthesis and Antiproliferative Activity Studies of Novel 1,2,3-Triazole Dithiocarbamate-Urea Hybrids[J]. Eur J Med Chem ,2013,64:99-110. [45] Zheng Y C,Duan Y C,Ma J L, et al . Triazole-Dithiocarbamate Based Selective Lysine Specific Demethylase 1(Lsd1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration[J]. J Med Chem ,2013,56(21):8543-8560. [46] Ye X W,Zheng Y C,Duan Y C, et al . Synthesis and Biological Evaluation of Coumarin-1,2,3-Triazole Dithiocarbamate Hybrids as Potent Lsd1 Inhibitors[J]. Med Chem Comm ,2014,5(5):650-654. [47] Ohtake N,Imamura H,Kiyonaga H, et al . Novel Dithiocarbamate Carbapenems1 with Anti-MRSA Activity[J]. Bioorg Med Chem Lett ,1997,7(13):1617-1622. [48] Ren J L,Zhang E,Ye X W, et al . Design, Synthesis and Antibacterial Evaluation of Novel AHL Analogues[J]. Bioorg Med Chem Lett ,2013,23(14):4154-4156. [49] Zou Y,Yu S,Li R, et al . Synthesis, Antifungal Activities and Molecular Docking Studies of Novel 2-(2,4-Difluorophenyl)-2-Hydroxy-3-(1 H -1,2,4-triazol-1-yl) Propyl Dithiocarbamates[J]. Eur J Med Chem ,2014,74:366-374. [50] Horita Y,Takii T,Chiba T, et al . Synthesis of New Sugar Derivatives and Evaluation of Their Antibacterial Activities Against Mycobacterium Tuberculosis[J]. Bioorg Med Chem Lett ,2009,19(22):6313-6316. [51] Güzel O,Salman A. Synthesis, Antimycobacterial and Antitumor Activities of New (1,1-Dioxido-3-Oxo-1,2-Benzisothiazol-2(3 H )-Yl)Methyl N , N -Disubstituted Dithiocarbamate/ O -Alkyldithiocarbonate Derivatives[J]. Bioorg Med Chem ,2006,14(23):7804-7815. [52] Giglio J,Fern ndez S,Rey A, et al . Synthesis and Biological Characterisation of Novel Dithiocarbamate Containing 5-Nitroimidazole 99mTc-Complexes as Potential Agents for Targeting Hypoxia[J]. Bioorg Med Chem Lett ,2011,21(1):394-397. |